Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
The Pharmalot View
STAT+

When should drugmakers go all in and cut off essential medicines to Russia?

  • Ed Silverman

By Ed Silverman March 19, 2022

Reprints
A woman walks past a pharmacy in Moscow in 2020. ALEXANDER NEMENOV/AFP via Getty Images

Just say nyet?

As the war in Ukraine intensifies, several of the world’s largest pharmaceutical companies have now joined hundreds of corporations in other industries that are cutting ties to Russia.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed Silverman covers the pharmaceutical industry.

Tags

Create a display name to comment

This name will appear with your comment

Senators probe telehealth companies for tracking and monetizing sensitive…
Senators probe telehealth companies for tracking and monetizing sensitive health data
‘They were his best shot. And they failed to…
‘They were his best shot. And they failed to help’: Why did EMS workers neglect Tyre…
New on the streets: Gabapentin, a drug for nerve…
New on the streets: Gabapentin, a drug for nerve pain, and a new target of misuse
Pharmalittle: Biden to call for expanding caps on insulin…
Pharmalittle: Biden to call for expanding caps on insulin prices; families seek to override Vertex CF…
Chinese DNA giant’s U.S. affiliate looks to rival Illumina,…
Chinese DNA giant’s U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers
Angry at Vertex pricing of cystic fibrosis drugs, families…
Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents

Recommended Stories